Werkgroep Cardiologische centra Nederland

GOLDILOX (Recruiting)

A Phase IIB, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants with a Prior Myocardial Infarction, Persistent Inflammation, and Elevated N-terminal Prohormone Brain Natriuretic Peptide
Medicine
MEDI6570
Population
ASCVD
Phase
IIB
Starting year
2020

Director of Study

drs. M.H.M. Winkens (Cardioloog)
Tilburg, ETZ locatie TweeSteden